Higher-risk patients include those in the dose-escalation phase, those with nausea, vomiting, bloating, abdominal pain, early satiety, or reflux symptoms, those on higher doses with GI side effects, and those with known gastroparesis or other conditions that slow gastric emptying
Those with Allergies to Copper: Though rare, some people have contact allergies to copper or specific peptide chains
Oncogene 29, 313324 (2010)
Furthermore, DON treatment sensitizes pancreatic cancer to anti-PD-1 therapy, further emphasizing its therapeutic significance [183]
Retatrutide has produced weight loss results that far exceed those of semaglutide (Ozempic), reducing weight by up to 24% in 48 weeks, compared to semaglutides 17.4% reduction after 68 weeks